EIGER BIOPHARMACEUTICALS - COM (EIGR)

Historical Institutional Holders from Q1 2016 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
0
Holdings value Q2 2024
0
Value change Q2 2024
0
Grand Portfolio weight change Q2 2024
0
Number of holders
0
Number of buys Q2 2024
0
Number of sells Q2 2024
0
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 21.3K $204K $0 $9.58 1
2024 Q1 0 $0 -$4.15M 0
2023 Q4 18.5M $4.16M -$1.6M $0.22 39
2023 Q3 19.9M $6.08M -$496K $0.31 47
2023 Q2 20.8M $14.6M -$3.02M $0.70 62
2023 Q1 24.8M $22.2M -$457K $0.90 68
2022 Q4 25.1M $29.6M -$37.7M $1.18 78
2022 Q3 29.8M $225M +$6.08M $7.53 88
2022 Q2 29.8M $188M -$6.86M $6.30 88
2022 Q1 30.3M $252M +$56.5M $8.30 95
2021 Q4 23.9M $124M +$5.61M $5.19 82
2021 Q3 22.6M $151M -$3.86M $6.68 89
2021 Q2 23M $196M -$5.31M $8.52 87
2021 Q1 23.4M $207M -$2.26M $8.85 92
2020 Q4 23.6M $290M +$24M $12.29 91
2020 Q3 22.3M $182M +$22.4M $8.14 100
2020 Q2 19.5M $187M +$18.1M $9.60 93
2020 Q1 17.8M $121M -$3.68M $6.80 89
2019 Q4 18.5M $275M -$8.78M $14.90 91
2019 Q3 18.7M $191M -$21.8M $10.25 82
2019 Q2 20.7M $220M +$46.3M $10.60 77
2019 Q1 15.4M $215M -$1.88M $13.98 62
2018 Q4 15.6M $158M +$54.8M $10.16 65
2018 Q3 9.82M $118M -$696K $12.00 50
2018 Q2 9.87M $120M +$36.9M $12.20 48
2018 Q1 6.95M $68.5M -$6.76M $9.85 37
2017 Q4 7.25M $101M +$23.3M $13.95 39
2017 Q3 4.95M $54.4M +$271K $11.00 30
2017 Q2 5.01M $39.6M -$9.13M $7.90 37
2017 Q1 5.79M $66.2M -$811K $11.45 47
2016 Q4 6.04M $70.4M -$1.08M $11.65 49
2016 Q3 4.52M $60.1M +$17.7M $13.39 45
2016 Q2 3.24M $62.6M +$3.91M $19.82 45
2016 Q1 3.05M $49.7M +$22.8M $16.77 27